CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice.
Akkerman, Alla; Huang, Weiqing; Wang, Xiaobo; Ramanujam, Meera; Schiffer, Lena; Madaio, Michael; Factor, Stephen M; Davidson, Anne.
; 37(6-7): 445-51, 2004 Sep-Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15621570
The catastrophic antiphospholipid syndrome in children.
Synthesis of Phospholipid-Protein Conjugates as New Antigens for Autoimmune Antibodies.
How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores.
Update on the pathogenesis and treatment of the antiphospholipid syndrome.
Antiphospholipid syndrome, "the best prophet of the future".
The Clinical Relevance of Noncriteria Antiphospholipid Antibodies.
Laboratory Diagnostics of Antiphospholipid Syndrome.
Reimagining the antiphospholipid syndrome, an enigmatic thrombophilic disorder, through the looking glass of microscopic imaging.
[Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
The contribution of antiphosphatidylethanolamine antibodies in the diagnosis of the antiphospholipid syndrome.